ASTER DM HEALTHCARE LTD Q3 RESULTS
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
ET Analysis: Indian hospital chains report revenue growth & expansion plans amidst regulatory concerns
Leading hospital chains in India have reported improved average revenue per operating bed (ARPOB) and profitability in the latest quarter, driven by better payer mix and cost control measures. Expansion plans are underway, with a focus on markets like Bengaluru and Mumbai, through asset-light models. Adjacent businesses such as diagnostics, virtual care, and digital healthcare platforms are also seeing growth. However, regulatory proposals to rationalize rates may pose risks to sector valuations.
Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?
Apollo Hospitals Share Price: Apollo Hospitals shares surged by 3.4% during Friday's early trading session, reaching a peak of Rs 5,955. This uptick followed the company's announcement of a significant 77% year-on-year (YoY) increase in its net profit.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
IRCTC, ABFRL, JSW Holdings among 453 companies declaring Q4 results on Tuesday
453 companies, including IRCTC and Aditya Birla Fashion, are set to declare Q4 results. Most companies report profits, boosting Nifty and Sensex to new highs. Market bullish ahead of Lok Sabha elections.
- Go To Page 1
Fortis Healthcare Q4 Results: Net profit jumps 47% YoY to Rs 203 crore
Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business.
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Do Dr Lal Pathlabs' results indicate a turnaround for the sector? 4 stocks from diagnostic space, 3 with upside potential of up to 31%
Some sectors have a company which can be called as the bell weather of that sector and that is why its results of that company probably are indicative of what is happening in the sector. In case of the diagnostic, it is probably the Dr Lals path labs which would fit the criteria, it has national presence, large network, present in both physical and digital segment. So when the quarterly numbers come and they show improvement on many fronts then probably it is time to have a look at them more seriously and see if there is a possible turnaround building in the sector. This became even more important because these stocks had gained extremely high valuation and also popularity in terms of both retail and institutional participation. But then for close to two years, they have been a strong under performer in a strong bull market. Does this result mean that finally in terms of price war for customer acquisition over and now the valuation readjustment will start in the upward direction.
Aster DM and 3 other stocks will trade ex-dividend next week
Here's a look at stocks that will trade ex-dividend in the coming week (April 22-26). (Source: StockEdge)
Technical Breakout Stocks: How to trade Aster DM Healthcare, Thermax and Exide Industries on Tuesday?
Sectorally, buying was seen in oil & gas and energy while selling was seen in IT, banks, capital goods, and power indices.
Aster DM Healthcare shares jump 14%, hit fresh record high on special dividend announcement
Aster DM Healthcare's Board approved the declaration of a special dividend of Rs 118/share payable to those shareholders whose names stand on the register of members of the company as of the record date of April 23, 2024
Stocks in news: TCS, Anand Rathi, Aster DM, Bharti Hexacom, Varun Beverages
IT bellwether TCS reported better than expected numbers for the fourth quarter ended March as its profit rose 9% year-on-year to Rs 12,434 crore. Revenue from operations, meanwhile, jumped 3.5% year-on-year.
Our plan is to be among top three healthcare players in next 3-5 years: Nitish Shetty, Aster DM Healthcare
60% of that 1,700 beds are going to be brownfield projects. When I say brownfield, it is an expansion of the existing infrastructure, existing hospitals, adding additional beds to the existing hospitals.
Stocks in news: Vodafone Idea, Aster DM Healthcare, DMart, Vedanta, RBL Bank
DIFC Dubai Branch has arranged for syndicated term loan of $500 million ($400 million and Green Shoe of $100 million) in two tranches with tenure of 3 years and 5 years.
Aster DM completes separation of Gulf business, plans to add 1,700 beds in India in next 3 years
Aster DM Healthcare has finalized the separation of its India and Gulf (GCC) businesses. A consortium led by Fajr Capital acquired a 65% stake in Aster GCC, while the Moopen family retained 35%. In India, the family holds a 41.88% stake. The separation aims to enhance strategic and financial flexibility.
Olympus Capital Asia divests 9.8% stake in Aster DM Healthcare for Rs 1,978 cr
According to the bulk deal data available with the BSE, more than 4.42 crore equity shares of Aster DM Healthcare were sold by Olympus Capital Asia Investments and 45.59 lakh shares by Olympus ACF Pte Ltd of the company. In a separate deal, Capital Group acquired shares of Aditya Vision, a financial services company, for Rs 95 crore.
Aster DM shares fall 7% after PE firm Olympus likely offloaded 10% stake via block deal
Aster DM shares were trading amid strong volumes with nearly 59 lakh shares being traded on the NSE around 10:45 am and the total traded value of the shares standing at Rs 242.50 crore.
Aster DM in final stage of Gulf business sale
Aster is planning to add 1500 beds by FY27 and aims to be among the top 3 hospital chains in India. The expansion plan will encompass a mix of brownfield and greenfield projects, contributing to the company's growth strategy. The company has planned an outlay of Rs. 850-900 crore which will ensure robust financial support for driving the expansion.
Aster DM Healthcare Q3 Results: Net profit rises 29% at Rs 179 crore
Aster DM Healthcare on Friday said its consolidated net profit increased 29 per cent to Rs 179 crore in the third quarter ended December 2023. The healthcare provider had reported a net profit of Rs 139 crore in the year-ago period.
Fortis Healthcare Q3 Results: Net profit drops 11% YoY to Rs 134 crore
The operating earnings before interest, tax, depreciation and amortisation (EBITDA) rose 6.8% YoY to Rs 284 crore. The EBITDA margins declined 80 basis points to 16.9%.
Metropolis Healthcare Q3 Results: Net profit drops 25% to Rs 27 crore
"The performance in Q3 was marginally impacted on account of heavy rainfall and floods in Chennai and adjacent areas in December 2023, leading to loss of revenues for approx. 7-8 days from Chennai region, which is one of the focus cities for Metropolis," Ameera Shah, promoter and managing director of Metropolis Healthcare said.
Max Healthcare Q3 Results: Net profit zooms 26% YoY to Rs 338 crore
Gross revenue rose 14% to Rs 1779 crore during Q3FY24 compared to Rs 1559 crore the previous year. The quarter-on-quarter (QoQ) basis revenue dropped 3%. The average revenue per occupied bed (ARPOB) increased 15% YoY to Rs.74,800 and the bed occupancy in Q3FY24 stood at 73%.
Max Healthcare Institute Q3 Results: Net profit rises 26% YoY to Rs 338 crore
Max Healthcare Institute Chairman and Managing Director Abhay Soi said the company continued to witness positive trends on all parameters even during this quarter. This translated into revenue and profitability growth, despite expected softness in occupancies due to the festive season.
Aster DM Healthcare to set up 55-acre solar project to power seven hospitals in Kerala
Aster DM Healthcare has announced plans to build a 55-acre solar plant in Kasargod, India, aimed at powering seven hospitals in Kerala. The project, part of the company's sustainable healthcare practices, is expected to produce 10 MW of power, with the first phase covering a 27-acre plot set for completion by March 2024.
Load More